Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa.
Sacedón R, de Arriba MC, Martínez-Santamaría L, Maseda R, Herráiz-Gil S, Jiménez E, Rosales I, Quintana L, Illera N, García M, Butta N, Fernández-Bello I, Lwin SM, Fernández-Arquero M, León C, McGrath JA, Vicente MÁ, Del Río M, de Lucas R, Sánchez-Ramón S, Escámez MJ. Sacedón R, et al. Among authors: garcia m. Br J Dermatol. 2023 Nov 16;189(6):774-776. doi: 10.1093/bjd/ljad313. Br J Dermatol. 2023. PMID: 37655918 No abstract available.
Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report.
Maseda R, Martínez-Santamaría L, Sacedón R, Butta N, de Arriba MDC, García-Barcenilla S, García M, Illera N, Pérez-Conde I, Carretero M, Jiménez E, Melen G, Borobia AM, Jiménez-Yuste V, Vicente Á, Del Río M, de Lucas R, Escámez MJ. Maseda R, et al. Among authors: garcia m, garcia barcenilla s. Front Med (Lausanne). 2020 Nov 26;7:576558. doi: 10.3389/fmed.2020.576558. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33324660 Free PMC article.
Evaluation of Systemic Gentamicin as Translational Readthrough Therapy for a Patient With Epidermolysis Bullosa Simplex With Muscular Dystrophy Owing to PLEC1 Pathogenic Nonsense Variants.
Martínez-Santamaría L, Maseda R, de Arriba MDC, Membrilla JA, Sigüenza AI, Mascías J, García M, Quintana L, Esteban-Rodríguez I, Hernández-Fernández CP, Illera N, Duarte B, Guerrero-Aspizúa S, Woodley DT, Del Río M, de Lucas R, Larcher F, Escámez MJ. Martínez-Santamaría L, et al. Among authors: garcia m. JAMA Dermatol. 2022 Apr 1;158(4):439-443. doi: 10.1001/jamadermatol.2022.0112. JAMA Dermatol. 2022. PMID: 35234827 Free PMC article.
Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing.
Bonafont J, Mencía Á, García M, Torres R, Rodríguez S, Carretero M, Chacón-Solano E, Modamio-Høybjør S, Marinas L, León C, Escamez MJ, Hausser I, Del Río M, Murillas R, Larcher F. Bonafont J, et al. Among authors: garcia m. Mol Ther. 2019 May 8;27(5):986-998. doi: 10.1016/j.ymthe.2019.03.007. Epub 2019 Mar 15. Mol Ther. 2019. PMID: 30930113 Free PMC article.
Assessment of optimal virus-mediated growth factor gene delivery for human cutaneous wound healing enhancement.
Escámez MJ, Carretero M, García M, Martínez-Santamaría L, Mirones I, Duarte B, Holguín A, García E, García V, Meana A, Jorcano JL, Larcher F, Del Río M. Escámez MJ, et al. Among authors: garcia m, garcia e, garcia v. J Invest Dermatol. 2008 Jun;128(6):1565-75. doi: 10.1038/sj.jid.5701217. Epub 2008 Jan 10. J Invest Dermatol. 2008. PMID: 18185534 Free article.
Long-term survival of type XVII collagen revertant cells in an animal model of revertant cell therapy.
Gostyński A, Llames S, García M, Escamez MJ, Martinez-Santamaria L, Nijenhuis M, Meana A, Pas HH, Larcher F, Pasmooij AMG, Jonkman MF, Del Rio M. Gostyński A, et al. Among authors: garcia m. J Invest Dermatol. 2014 Feb;134(2):571-574. doi: 10.1038/jid.2013.308. Epub 2013 Jul 24. J Invest Dermatol. 2014. PMID: 23884316 Free article. No abstract available.
10,113 results
You have reached the last available page of results. Please see the User Guide for more information.